Dr. Sherry Shen, MD
Claim this profileMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Area of expertise
Breast Cancer
Sherry Shen, MD has run 2 trials for Breast Cancer. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Clinical Trials Sherry Shen, MD is currently running
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting
2 awards
Phase 3
12 criteria
Lenvatinib + Pembrolizumab + Fulvestrant
for Breast Cancer
The purpose of this study is to test whether the combination of lenvatinib, pembrolizumab, and fulvestrant is a safe and effective treatment that causes few or mild side effects in people with ER+/HER2- metastatic breast cancer.
Recruiting
1 award
Phase 1 & 2
20 criteria
More about Sherry Shen, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Sherry Shen, MD has experience with
- Fulvestrant
- Lenvatinib
- Pembrolizumab
- Abemaciclib
- Lasofoxifene
Breakdown of trials Sherry Shen, MD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sherry Shen, MD specialize in?
Sherry Shen, MD focuses on Breast Cancer and other conditions. In particular, much of their work with Breast Cancer has involved ER positive patients, or patients who are Stage IV.
Is Sherry Shen, MD currently recruiting for clinical trials?
Yes, Sherry Shen, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Sherry Shen, MD has studied deeply?
Yes, Sherry Shen, MD has studied treatments such as Fulvestrant, Lenvatinib, Pembrolizumab.
What is the best way to schedule an appointment with Sherry Shen, MD?
Apply for one of the trials that Sherry Shen, MD is conducting.
What is the office address of Sherry Shen, MD?
The office of Sherry Shen, MD is located at: Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center (All Protocol Activities).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.